CLEANMAXClean Max Enviro Energy Solutions Ltd.
Clean Max Enviro Energy Solutions to sell 26% stake in Clean Max Alps for ₹26,000
- Mergers & acquisitions
- Renewable energy

Clean Max Enviro Energy Solutions (NSE: CLEANMAX) has approved the sale of 2,600 shares, or 26% of the paid-up share capital of its wholly owned subsidiary Clean Max Alps Private Limited, to Bayer Vapi Private Limited for ₹26,000, it said in a filing on 30 Oct 2026.
The sale in detail
The board of Clean Max Enviro Energy Solutions Limited approved the sale on 30 Oct 2026. The company will enter into a Share Purchase Agreement with Bayer Vapi Private Limited on or before 31 Dec 2026, or on another date the parties agree, and completion is expected by the same date.
The sale consideration is ₹26,000 for the 2,600 shares. It will be received after the Share Purchase Agreement is executed between the company, Clean Max Alps Private Limited and Bayer Vapi Private Limited. Bayer Vapi Private Limited is registered at Vapi, Gujarat, and the company says the buyer does not belong to the promoter or promoter group.
Clean Max Alps Private Limited was incorporated under the Companies Act, 2013 on 18 Dec 2024. The company says it has not contributed to turnover, revenue, income or net worth in the last financial year.
How it fits the company
The company's latest quarter, Q1 FY27 on a consolidated basis, reported total income of ₹874.10 crore and net profit of ₹55.17 crore. The consideration of ₹26,000 is small against that base.
What the sale means for Clean Max Enviro Energy Solutions' shareholders
The filing does not say why the stake is being sold, what the subsidiary's business is, how much capital has been put into it, or whether the Share Purchase Agreement has been signed.
The next dated step is the Share Purchase Agreement, due on or before 31 Dec 2026.
At a glance
| Item | Detail |
|---|---|
| Subsidiary | Clean Max Alps Private Limited |
| Incorporated | 18 Dec 2024 |
| Shares sold | 2,600 shares (26%) |
| Sale consideration | ₹26,000 |
| Buyer | Bayer Vapi Private Limited |
| Expected completion | On or before 31 Dec 2026 |
Filed with NSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.